Sugi Predict

Sugi Predict / Compounds / SCHEMBL1748298

SCHEMBL1748298

SCHEMBL1748298

Fc1ccc2sc(Cl)nc2c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.43
▸ SMN1; SMN2 Q16637 6/20 0.35
▸ LMNA P02545 4/20 0.35
▸ RAB9A P51151 4/20 0.34
▸ GAA P10253 3/20 0.34
▸ NPC1 O15118 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ PRNP P04156 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ AKR1B1 P15121 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ IDO1 P14902 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PDE10A Q9Y233 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3833304 0.79 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2LMNARAB9AGAA
SCHEMBL2748639 0.76 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2LMNARAB9AGAA
SCHEMBL335937 0.76 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2LMNARAB9ANPC1
SCHEMBL2634141 0.76 SMN1; SMN2 (0.61) ALDH1A1SMN1; SMN2LMNARAB9AGAA
SCHEMBL30904497 0.76 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2LMNARAB9AGAA
SCHEMBL8396300 0.73 MEN1 (0.43) ALDH1A1SMN1; SMN2LMNARAB9ANPC1
SCHEMBL23290946 0.72 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2LMNARAB9AGAA
SCHEMBL10515929 0.72 AKR1B1 (0.42) ALDH1A1SMN1; SMN2LMNARAB9AGAA
SCHEMBL29872373 0.71 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNARAB9AGAA
SCHEMBL7836861 0.68 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNARAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178668-B2 2-aminopyridine kinase inhibitors OSI Pharmaceuticals, LLC (US) 2012-05-15 — — US disclosed
EP-1633722-B1 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER HEALTHCARE LLC (US) 2011-08-03 — — EP disclosed
US-7968576-B2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity SMITH ROGER A 2011-06-28 — — US disclosed
EP-2265270-A1 2-AMINOPYRIDINE KINASE INHIBITORS OSI Pharmaceuticals, Inc. (US) 2010-12-29 — — EP disclosed
US-20090253762-A1 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY SMITH ROGER 2009-10-08 — — US disclosed
WO-2009099982-A1 2-AMINOPYRIDINE KINASE INHIBITORS OSI PHARMACEUTICALS, INC. (US) 2009-08-13 — — WO disclosed
US-20090197862-A1 2-AMINOPYRIDINE KINASE INHIBITORS OSI PHARMACEUTICALS, INC. 2009-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253762-A1 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY FABP4, GPR119, LIPC ALDH1A1 199/4885SMN1; SMN2 3975/4885LMNA 844/4885
US-20090197862-A1 2-AMINOPYRIDINE KINASE INHIBITORS ERBB2, ABL2, TIE1 ALDH1A1 945/4885SMN1; SMN2 763/4885LMNA 3582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.